Displaying drugs 11326 - 11350 of 13807 in total
MYR-101
MYR-101 (rAAV-Olig001-ASPA) is a recombinant adeno-associated virus (rAAV) vector-based gene therapy intended to treat Canavan disease. Canavan disease is a fatal childhood genetic disorder characterized by white matter degeneration in the brain. It is caused by a mutation in the aspartoacylase gene (ASPA), which leads to a deficiency of the...
Investigational
Matched Description: … It is caused by a mutation in the aspartoacylase gene (_ASPA_), which leads to a deficiency of the aspartoacylase ... MYR-101 (rAAV-Olig001-ASPA) is a recombinant adeno-associated virus (rAAV) vector-based gene therapy ... Canavan disease is a fatal childhood genetic disorder characterized by white matter degeneration in the …
Ezurpimtrostat
Investigational
Matched Iupac: … 4-[4-(tert-butylamino)piperidin-1-yl]-N-[(4-chlorophenyl)methyl]quinolin-2-amine …
(3-Formyl-but-3-Enyl)-Phosphonic Acid
Experimental
Indium In-111 altumomab pentetate
Investigational
Lyophilized activated platelets
Investigational
Coltuximab ravtansine
Coltuximab ravtansine (SAR3419) targets CD19 and is being investigated for the treatment of acute lymphoblastic leukemia (ALL).
Investigational
N-[4-(4-nitrophenylphospho)butanoyl]-L-alanine
Experimental
Matched Iupac: … (2S)-2-{4-[hydroxy(4-nitrophenoxy)phosphoryl]butanamido}propanoic acid …
Brodimoprim
Experimental
1-Aminocyclopropylphosphonate
Experimental
Phosphonoacetohydroxamic Acid
Experimental
Ethyl-Carbamic Acid Methyl Ester
Experimental
3-(BUTYLSULPHONYL)-PROPANOIC ACID
Experimental
Potassium hydrogen DL-aspartate
Experimental
Tominersen
Investigational
α-Methylfentanyl
α-Methylfentanyl is an analog of fentanyl with opioid analgesic properties.
Illicit
Matched Iupac: … N-phenyl-N-[1-(1-phenylpropan-2-yl)piperidin-4-yl]propanamide …
Coagulin-B
Coagulin-B is an adeno-associated viral vector expressing human blood-coagulation Factor IX.[A259038, A259043] It was previously investigated for the treatment of hemophilia; however, the manufacturing company discontinued the Phase I trial in 2004, halting its further development and investigation.
Investigational
Nurulimab
Nurulimab is under investigation in clinical trial NCT05732805 (A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-pd-1 Compared to Anti-pd-1 Monotherapy as First-line Treatment in Subjects With Unresectable/metastatic Melanoma).
Investigational
Matched Description: … Nurulimab is under investigation in clinical trial NCT05732805 (A Clinical Study of BCD-217 (Nurulimab …
Ulinastatin
Ulinastatin has been investigated for the prevention of Cardiovascular Disease and Adverse Reaction to Drug.
Investigational
Myristyl glyceryl ether
Experimental
L-alpha-Glycerophosphorylethanolamine
Experimental
Matched Iupac: … (2-aminoethoxy)[(2R)-2,3-dihydroxypropoxy]phosphinic acid …
LB54640
LB54640 is orally-administered small molecule agonist of the melanocortin 4 receptor.
Investigational
3-thiaoctanoyl-CoA
Experimental
Matched Synonyms: … 3-thiaoctanoyl-coenzyme A …
Matched Iupac: … -3-({2-[(2-{[2-(pentylsulfanyl)acetyl]sulfanyl}ethyl)carbamoyl]ethyl}carbamoyl)propoxy]phosphoryl}oxy ... {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({hydroxy[(3R)-3-hydroxy-2,2-dimethyl …
Matched Iupac: … -3-({2-[(2-{[2-(pentylsulfanyl)acetyl]sulfanyl}ethyl)carbamoyl]ethyl}carbamoyl)propoxy]phosphoryl}oxy ... {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({hydroxy[(3R)-3-hydroxy-2,2-dimethyl …
RR001
RR001 is an investigational gene therapy consisting of autologous human adipose perivascular stromal cells genetically modified to secrete soluble tumour necrosis factor-related apoptosis-inducing ligand (AD-PC sTRAIL).
Investigational
Displaying drugs 11326 - 11350 of 13807 in total